NCT04084327Unknown不适用
Immunophenotyping of Acute b Cell Lymphoblastic Leukemia
South Egypt Cancer Institute0 个研究点目标入组 50 人开始时间: 2019年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 50
- 主要终点
- Disease-free survival outcome
研究概览
简要总结
To study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute iand its correlation with disease outcome
详细描述
study the immunophenotyping pattern of acute B lymphoblastic leukemia in south Egypt Cancer Institute from 2009 -2019 and its correlation with disease outcome
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 12 Months 至 80 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •New cases admitted to SECI Who didn't receive treatment.Age above 1 years old.
排除标准
- •Cases who received treatment Patients below 1 years old.Patients diagnosed as AML or T-ALL
结局指标
主要结局
Disease-free survival outcome
时间窗: 10 years
Disease-free survival outcome
association of novel CD markers with old markers for assessment of disease outcome
时间窗: 10 years
association of novel CD markers with old markers for assessment of disease outcome
overall survival outcome
时间窗: 10 years
overall survival outcome
次要结局
未报告次要终点
研究者
ayat ahmed mohamed
principle investigator
South Egypt Cancer Institute
相似试验
Unknown
不适用
Comparative Autoantibody and Immunologic Cell Marker StudyAutoimmune DiseasesLupus Erythematosus, SystemicCommunicable DiseasesNCT02422875Emory University2,500
招募中
2 期
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALLPrecursor B-Cell Lymphoblastic LeukemiaNCT06554626First Affiliated Hospital of Zhejiang University20
已完成
不适用
Abnormalities of B Lymphocytes During Systemic LupusSystemic Lupus ErythematosusNCT00401141University Hospital, Strasbourg, France30
终止
4 期
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaLeukemia RelapseNCT02618109University Hospital, Angers119
撤回
不适用
Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral SclerosisNCT00846560Rambam Health Care Campus